Back to top
more

abrdn Life Sciences Investors: (HQL)

(Delayed Data from NYSE) As of Apr 16, 2024 03:49 PM ET

$12.85 USD

12.8534
71,704

-0.12 (-0.94%)

Volume: 71,704

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

NA

After-Market: $12.82 -0.03 (-0.26 %) 4:40 PM ET

ETF Quote Details

Previous Close 12.98
Open 12.93
Bid 12.85
Ask 12.87
Day Low-High 12.83-12.98
52wk Low-High 11.34-14.37
Volume 71,704
NAV (month end) 16.13
Premium (+)/Discount (-) (month end)-3.16

Zacks Premium Research for HQL

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

 NA
ETF Risk

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

NA

ETF Expense Ratio

Expense Ratio 1.35%
Dividend (Yield) $1.33 (10.25%)
Issuer ABRDN ETFS

Benchmark for HQL

NASDAQ BIOTECH

Fund Summary for HQL

ABRDN LIFE SCIENCES INVESTORS

The abrdn Life Sciences Investors seeks long-term capital appreciation by investing in securities of Life Sciences companies.